Ping An Biomedical Co., Ltd. (PASW)
NASDAQ: PASW · Real-Time Price · USD
1.040
+0.130 (14.29%)
At close: Oct 7, 2025, 4:00 PM EDT
1.030
-0.010 (-0.96%)
After-hours: Oct 7, 2025, 6:33 PM EDT

Ping An Biomedical Income Statement

Millions CNY. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
60.1387.6282.56114.5599.5255.46
Revenue Growth (YoY)
-37.53%6.13%-27.92%15.10%79.43%-
Cost of Revenue
59.0982.2178.32100.485.2544.8
Gross Profit
1.045.424.2414.1414.2710.67
Selling, General & Admin
5.515.33.63.523.763.05
Operating Expenses
5.765.423.633.3366.21
Operating Income
-4.72-00.6110.828.274.46
Interest Expense
-0.35-0.71-1.74-1.57-1.36-1.04
Interest & Investment Income
000.160.0400.01
Currency Exchange Gain (Loss)
-0.01-0.010.21-00.190.05
Other Non Operating Income (Expenses)
-0.090.030.80.340.720
Pretax Income
-5.16-0.680.049.637.823.48
Income Tax Expense
0.60.61.042.42.611.55
Net Income
-5.75-1.28-0.997.235.211.92
Net Income to Common
-5.75-1.28-0.997.235.211.92
Net Income Growth
---38.61%170.96%-
Shares Outstanding (Basic)
181818181818
Shares Outstanding (Diluted)
181818181818
EPS (Basic)
-0.32-0.07-0.060.400.290.11
EPS (Diluted)
-0.32-0.07-0.060.400.290.11
EPS Growth
---38.61%170.96%-
Free Cash Flow
11.0414.63-6.0821.06-31.4-7.18
Free Cash Flow Per Share
0.610.81-0.341.17-1.74-0.40
Gross Margin
1.73%6.18%5.14%12.35%14.34%19.23%
Operating Margin
-7.85%-0.00%0.74%9.44%8.31%8.04%
Profit Margin
-9.57%-1.47%-1.20%6.31%5.24%3.47%
Free Cash Flow Margin
18.35%16.70%-7.37%18.39%-31.55%-12.95%
EBITDA
-4.710.010.6510.848.294.46
EBITDA Margin
-7.84%0.01%0.78%9.46%8.33%8.05%
D&A For EBITDA
0.010.010.030.020.020
EBIT
-4.72-00.6110.828.274.46
EBIT Margin
-7.85%-0.00%0.74%9.44%8.31%8.04%
Effective Tax Rate
--2484.34%24.92%33.32%44.67%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.